by Rod Raynovich | Sep 9, 2011 | Macro
Imminent Greek Default? Buyers on Hold for the Weekend The familiar pattern comes back to haunt US markets as an ECB official resigned sparking a downdraft within 1o minutes. Jurgen Stark, a German who sits on the Board of the European Central Bank is an opponent of...
by Rod Raynovich | Aug 31, 2011 | 2024-25 Life Science Portfolios, Macro
Worse August in a Decade Down 6%-Economic Data Still Foreboding and Macro Headwinds Remain If you were on vacation for the month of August and reviewed your “balanced” portfolio today you might wonder what everyone was freaking out about. Treasuries were...
by Rod Raynovich | Aug 26, 2011 | 2024-25 Life Science Portfolios, BIOgraph, Macro
Can Congress Ignore a 78% Disapproval Rating? All the anticipation of the FED and Jackson Hole went to the ZEN mode-do nothing and the market will rally. Investors apparently were interpreting this as the economy isn’t bad enough to warrant stimulus. Around...
by Rod Raynovich | Aug 25, 2011 | BIOgraph, Macro
A day before the Bernanke addresses the public on potential FED plans and the state of the economy the market reverted back to the Euro Debt crisis selling tracking the European stocks decline. The market major indices sold off 1.5% while the FTSE-100 was off 1.44%....
by Rod Raynovich | Aug 24, 2011 | BIOgraph, Macro
Drug Stocks with Dividends for Safety and Appreciation On Monday AM we thought blue chip drug and biotech stocks were poised to rally and we were rewarded. The S&P has come back to early August depressed levels but we have a double bottom in August. Healthcare...
by Rod Raynovich | Aug 21, 2011 | BIOgraph, Macro
Got Gold and U.S. Treasuries? It is impossible to really describe the market turmoil in the space below so let this post from Investor Uprising suffice. With 10 Year treasuries under 2% and Gold approaching $1900 fear is pervasive. Bankers meet in Jackson Hole next...
by Rod Raynovich | Aug 4, 2011 | BIOgraph, Macro
Global Debt Crisis Weighs In-Everything is Interconnected Panic selling has eased after European market closes but we are still down 3%. 10 Year treasuries are under 2.5%.Banks cannot handle the flow of money to safety and may actually charge for opening an account....
by Rod Raynovich | Aug 1, 2011 | 2024-25 Life Science Portfolios, BIOgraph, Macro
Triggers: Debt Ceiling and Skilled Nursing Stocks There is a broad sell-off in healthcare stocks today on fears that the debt ceiling deal would cut healthcare spending.A few weeks ago a few hedgies were on CNBC touting their “short healthcare” trade so...
by Rod Raynovich | Jul 27, 2011 | BIOgraph, Macro
Weakness in tools such as ILMN ($59.30) down 15% is hurting biotech. Also our mid cap biopharma index is down 2.5% . So the NASDAQ-100 is favored due to the inclusion of AAPL, AMZN, INTC and MSFT etc and larger cap biotech stocks.
by Rod Raynovich | Jul 25, 2011 | BIOgraph, Macro
Note: we will return from vacation this week and focus on companies attending the AACC (American Association of Clinical Chemistry)Meeting in Atlanta this week). Market Down 0.5% as Both Parties Struggle to Come up with Debt Ceiling Plan One half hour into trading...
